Toyota Global Sales Fall as China Demand Slumps 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Add as a preferred source on Google
CUPERTINO, CA, April 12, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) today announced that Universal Biofuels, the company’s India subsidiary, is producing glycerin at above nameplate capacity and demand for the product exceeds supply. The production capacity of the refined glycerin unit at the Kakinada plant is approximately 18,000 metric tonnes per year. The sale of glycerin is an important part of the company’s business strategy in India.
“Our glycerin refining facility in India is operating above nameplate capacity by importing crude glycerin from Argentina and other biodiesel production countries,” stated Eric McAfee, Chairman and CEO of Aemetis. “As our plant scales up biodiesel production using the new pre-treatment unit, the refined glycerin production unit has grown to be an important source of consistent revenues and contribution margins supplying the production of consumer and paint products in India.”
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected]
